Equity Capital Markets

Company · CIK 1743881

BridgeBio Pharma, Inc.

CIK1743881 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedBBIO (Nasdaq)
First annual or quarterly report2019-08-14

Offerings

8 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-297701
ShelfEffective
 2026-07-242026-07-241
333-295678
ShelfEffective
 2026-05-082026-05-081
333-271650
ShelfEffective
 2023-05-042024-03-063
333-275280
ShelfEffective
 2023-11-022023-11-021
333-273452
ShelfEffective
 2023-07-262023-07-261
333-239734
ShelfEffective
 2020-07-072023-03-093
333-240147
ShelfEffective
 2020-07-282020-07-281
333-231759
IPOFinal prospectus
 2019-05-242019-06-287

Filings

20
FiledFilingRegistrationAccession
2026-07-24S-3ASRShelf registered 333-2977010001140361-26-029624
2026-05-08S-3ASRShelf registered 333-2956780001140361-26-019654
2024-03-06424B5Shelf takedown 333-2716500001140361-24-011764
2024-03-04424B5Shelf takedown 333-2716500001140361-24-011117
2023-11-02S-3ASRShelf registered 333-2752800001140361-23-051194
2023-07-26S-3ASRShelf registered 333-2734520001140361-23-036235
2023-05-04S-3ASRShelf registered 333-2716500001193125-23-136048
2023-03-09424B5Shelf takedown 333-2397340001193125-23-065456
2023-03-06424B5Shelf takedown 333-2397340001193125-23-061614
2020-12-15EFFECTDeclared effective 333-2499449999999995-20-003530
2020-07-28S-3ASRShelf registered 333-2401470001193125-20-201049
2020-07-07S-3ASRShelf registered 333-2397340001193125-20-188892
2019-06-28424B4Final prospectus 333-2317590001193125-19-186080
2019-06-26EFFECTDeclared effective 333-2317599999999995-19-001448
2019-06-26S-1/AAmendment 333-2317590001193125-19-181551
2019-06-24S-1/AAmendment 333-2317590001193125-19-179321
2019-06-17S-1/AAmendment 333-2317590001193125-19-174178
2019-06-11S-1/AAmendment 333-2317590001193125-19-169677
2019-05-24S-1Registration filed 333-2317590001193125-19-157100
2019-02-14DRSDraft made public 377-025130000950123-19-002230

All filings of this company · CSV